Itonis Inc (ITNS) 0.0110 $ITNS
Itonis Pharmaceuticals Announces First Emesyl(R) Manufacturer Production Release Date
Marketwire - Tue Aug 12, 7:31AM CDT
Itonis, Inc. (PINKSHEETS: ITNS)
Itonis Pharmaceuticals Authorizes Start of Emesyl(R) Inaugural Production Run
Marketwire - Wed Jun 25, 7:03AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) Itonis is pleased to announce that, with the finalization of its new packaging design and product labeling, it has given the go ahead to Oasis Health Products to produce 16,000 units of its Emesyl(R) homeopathic product. Itonis has pre-paid necessary funds to Oasis to commence the inaugural production run.
Itonis Pharmaceuticals Completes Final Package Design, Enabling Start of Emesyl(R) Production
Marketwire - Thu Jun 19, 9:00AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) is pleased to announce that the final product packaging and bottle label designs for its Emesyl(R) over-the-counter homeopathic product for nausea relief are now complete. The finalized packaging design includes the 800 product phone number, the product information website, the product UPC code, and a brand new visual look that is very appealing to consumers. New pictures of the final box and bottle designs can be found on the company's website news tab at # http://www.itonisholdings.com/news.
COREwafer Industries Inc.'s Stock Volume Soars amid Lawsuits and Hidden Debt
ACCESSWIRE - Tue Apr 01, 9:02AM CDT
COREwafer Industries Inc.'s (OCTPINK: WAFR) share volume soared Mar. 31, with 92,841,276 shares changing hands, nearly double its three-month average volume of 47,097,800 shares.
Itonis, Inc. Joins the National Cannabis Industry Association to Advance Into the Medical Marijuana Products and Services Sector
Marketwire - Tue Apr 01, 8:03AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) today announced that it has joined the National Cannabis Industry Association (NCIA) as a member in a part of the Company's preparations to expand into the medical marijuana products and services sector. The Company is positioning itself for tremendous opportunities in this vibrant sector in unison with its recent app licensing agreement with MyECheck, Inc.
Itonis Inc. Signs Licensing Agreement with MyECheck Inc. for Medical Marijuana Point of Purchase App
ACCESSWIRE - Tue Apr 01, 12:45AM CDT
Itonis Inc. (OTC: ITNS) has signed a Licensing Agreement with MyECheck, Inc. that opens the gates for Itonis to possibly become a leading player in the blossoming medical marijuana industry. In the licensing agreement, Itonis will acquire a software license for MyECheck's patented mobile payment app that will facilitate point of purchase transactions for medical marijuana, gambling, and general retail sales. There is no expiration date on that license. The company believes there is a significant revenue opportunity in addressing the demand regarding medical marijuana and the point of sales from medical suppliers.
Itonis, Inc. OTCpink ITNS today announced that it has signed a Licensing Agreement with MyECheck,OTCpink MYEC
M2 - Fri Mar 28, 12:50PM CDT
March 28, 2014 Vancouver (321gostocks) -- Itonis, Inc. (PINKSHEETS: ITNS) today announced that it has signed a Licensing Agreement with MyECheck, Inc. for Itonis to acquire a software license for MyECheck's patented mobile payment app that will facilitate point of purchase transactions for medical marijuana, gambling, and general retail sales. There is no expiration date on that license.
Itonis, Inc. Signs App License Agreement With MyECheck, Inc. for Medical Marijuana Point of Purchase App
Marketwire - Fri Mar 28, 10:14AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) today announced that it has signed a Licensing Agreement with MyECheck, Inc. for Itonis to acquire a software license for MyECheck's patented mobile payment app that will facilitate point of purchase transactions for medical marijuana, gambling, and general retail sales. There is no expiration date on that license.
Itonis, Inc. Update on Company Direction With Emesyl and Licensing of App for Medical Marijuana Point of Purchase
Marketwire - Wed Mar 26, 10:29AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) today issued the following update to its shareholders:
Arotech Corporation Announces More than $2M in Orders; DirectView Holdings Plans to Open a Colorado Office
ACCESSWIRE - Tue Mar 25, 11:26PM CDT
Arotech Corporation (NASDAQ: ARTX) - For an in-depth report on Arotech Corporation follow: www.BullTrends.com/stockquote/ARTX
Itonis Pharmaceuticals Completed Evaluation of Emesyl Product to Take Next Step to Manufacturing
Marketwire - Wed Mar 19, 10:00AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) is pleased to announce that Charles Hensley, PhD., the inventor of the Zicam(R) cold remedy, and his team has completed their evaluation of the manufactured samples of Emesyl(TM), the company's over-the-counter homeopathic product for nausea relief.
Itonis, Inc. Signs LOI With MyECheck, Inc. for Licensing of App for Medical Marijuana Point of Purchase
Marketwire - Mon Mar 17, 2:29PM CDT
Itonis, Inc. (PINKSHEETS: ITNS) is pleased to announce that it has entered into a Letter of Intent with MyECheck, Inc. to acquire a software license for MyECheck's patented mobile payment app that will facilitate point of purchase transactions for medical marijuana, gambling, and general retail sales.
Itonis Pharmaceuticals Received Emesyl Samples for Evaluation
Marketwire - Fri Feb 28, 12:50PM CST
Itonis, Inc. (PINKSHEETS: ITNS) is pleased to announce that it has received and is currently evaluating samples of its Emesyl(TM) product from its manufacturer. Oasis Health Products, Inc. delivered two versions of the Emesyl(TM) anti-nausea formula which are currently being evaluating for tolerance.
Itonis Pharmaceuticals and Charles Hensley, Ph.D. to Begin Distributing Emesyl(TM) Anti-Nausea Homeopathic Product in Mexico
Marketwire - Thu Sep 12, 7:30AM CDT
Itonis, Inc.'s pharmaceutical division (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) Cold Remedy, are pleased to announce that Hensley Brothers Distribution, LLC ("HBD"
will distribute Emesyl((TM)), the Company's over-the-counter homeopathic product for nausea relief, to Mexico through one of HBD's distribution partners.
Itonis Pharmaceuticals, Led by Dr. Charles Hensley, the Inventor of Zicam(R) Cold Remedy, Received FDA Labeler Status
Marketwire - Wed Jul 31, 8:02AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce that the Company has received its labeler's code from the federal Food and Drug Administration (FDA).
Charles Hensley, Ph.D., Inventor of Zicam(R) Cold Remedy, and Itonis Pharmaceuticals to Distribute Homeopathic Products in Retail Chains
Marketwire - Fri Jul 19, 8:45AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce that the Company's line of homeopathic products will be distributed nationally and internationally by Hensley Brothers Distribution, LLC.
Charles Hensley, Ph.D., Inventor of Zicam(R) Cold Remedy, and Itonis Pharmaceuticals to Obtain FDA Labeler Status
Marketwire - Tue Jun 25, 1:30PM CDT
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce the Company has commenced the application process to file with the U.S. Food and Drug Administration as a labeler.
Charles Hensley, Ph.D., Inventor of Zicam(r) Cold Remedy, And Itonis Pharmaceuticals Prepared to File for the National Drug Code Number for the Emesyl(tm) Anti-Nausea Products to Launch Sales in Fall 2013
GlobeNewswire - Fri May 31, 8:30AM CDT
Itonis, Inc. (OTC: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) Cold Remedy, and founding member of Itonis Pharmaceuticals, are pleased to announce the Company is prepared to file for the National Drug Code (NDC) number for their over-the-counter Emesyl(TM) homeopathic product.
Charles Hensley, Ph.D., Inventor of Zicam(r) Cold Remedy And Itonis Pharmaceuticals to Finalized Product Packaging For The Emesyl Anti-Nausea Products
GlobeNewswire - Thu May 30, 11:53AM CDT
Itonis, Inc. (OTC: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) Cold Remedy, and founding member of Itonis Pharmaceuticals, are pleased to announce the finalization of the packaging graphics for their over-the-counter homeopathic product EmesylTM which can be viewed at the Company's website at www.itonisholdings.com.
Charles Hensley, Ph.D., Inventor of Zicam(r) Cold Remedy And Itonis Pharmaceuticals Finalized Product Packaging For The Emesyl Anti-Nausea Products
GlobeNewswire - Thu May 30, 10:00AM CDT
Itonis, Inc. (OTC: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) Cold Remedy, and founding member of Itonis Pharmaceuticals, are pleased to announce the finalization of the packaging graphics for their over-the-counter homeopathic product EmesylTM which can be viewed at the Company's website at www.itonisholdings.com.
Itonis Pharmaceuticals Announces First Emesyl(R) Manufacturer Production Release Date
Marketwire - Tue Aug 12, 7:31AM CDT
Itonis, Inc. (PINKSHEETS: ITNS)
Itonis Pharmaceuticals Authorizes Start of Emesyl(R) Inaugural Production Run
Marketwire - Wed Jun 25, 7:03AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) Itonis is pleased to announce that, with the finalization of its new packaging design and product labeling, it has given the go ahead to Oasis Health Products to produce 16,000 units of its Emesyl(R) homeopathic product. Itonis has pre-paid necessary funds to Oasis to commence the inaugural production run.
Itonis Pharmaceuticals Completes Final Package Design, Enabling Start of Emesyl(R) Production
Marketwire - Thu Jun 19, 9:00AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) is pleased to announce that the final product packaging and bottle label designs for its Emesyl(R) over-the-counter homeopathic product for nausea relief are now complete. The finalized packaging design includes the 800 product phone number, the product information website, the product UPC code, and a brand new visual look that is very appealing to consumers. New pictures of the final box and bottle designs can be found on the company's website news tab at # http://www.itonisholdings.com/news.
COREwafer Industries Inc.'s Stock Volume Soars amid Lawsuits and Hidden Debt
ACCESSWIRE - Tue Apr 01, 9:02AM CDT
COREwafer Industries Inc.'s (OCTPINK: WAFR) share volume soared Mar. 31, with 92,841,276 shares changing hands, nearly double its three-month average volume of 47,097,800 shares.
Itonis, Inc. Joins the National Cannabis Industry Association to Advance Into the Medical Marijuana Products and Services Sector
Marketwire - Tue Apr 01, 8:03AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) today announced that it has joined the National Cannabis Industry Association (NCIA) as a member in a part of the Company's preparations to expand into the medical marijuana products and services sector. The Company is positioning itself for tremendous opportunities in this vibrant sector in unison with its recent app licensing agreement with MyECheck, Inc.
Itonis Inc. Signs Licensing Agreement with MyECheck Inc. for Medical Marijuana Point of Purchase App
ACCESSWIRE - Tue Apr 01, 12:45AM CDT
Itonis Inc. (OTC: ITNS) has signed a Licensing Agreement with MyECheck, Inc. that opens the gates for Itonis to possibly become a leading player in the blossoming medical marijuana industry. In the licensing agreement, Itonis will acquire a software license for MyECheck's patented mobile payment app that will facilitate point of purchase transactions for medical marijuana, gambling, and general retail sales. There is no expiration date on that license. The company believes there is a significant revenue opportunity in addressing the demand regarding medical marijuana and the point of sales from medical suppliers.
Itonis, Inc. OTCpink ITNS today announced that it has signed a Licensing Agreement with MyECheck,OTCpink MYEC
M2 - Fri Mar 28, 12:50PM CDT
March 28, 2014 Vancouver (321gostocks) -- Itonis, Inc. (PINKSHEETS: ITNS) today announced that it has signed a Licensing Agreement with MyECheck, Inc. for Itonis to acquire a software license for MyECheck's patented mobile payment app that will facilitate point of purchase transactions for medical marijuana, gambling, and general retail sales. There is no expiration date on that license.
Itonis, Inc. Signs App License Agreement With MyECheck, Inc. for Medical Marijuana Point of Purchase App
Marketwire - Fri Mar 28, 10:14AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) today announced that it has signed a Licensing Agreement with MyECheck, Inc. for Itonis to acquire a software license for MyECheck's patented mobile payment app that will facilitate point of purchase transactions for medical marijuana, gambling, and general retail sales. There is no expiration date on that license.
Itonis, Inc. Update on Company Direction With Emesyl and Licensing of App for Medical Marijuana Point of Purchase
Marketwire - Wed Mar 26, 10:29AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) today issued the following update to its shareholders:
Arotech Corporation Announces More than $2M in Orders; DirectView Holdings Plans to Open a Colorado Office
ACCESSWIRE - Tue Mar 25, 11:26PM CDT
Arotech Corporation (NASDAQ: ARTX) - For an in-depth report on Arotech Corporation follow: www.BullTrends.com/stockquote/ARTX
Itonis Pharmaceuticals Completed Evaluation of Emesyl Product to Take Next Step to Manufacturing
Marketwire - Wed Mar 19, 10:00AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) is pleased to announce that Charles Hensley, PhD., the inventor of the Zicam(R) cold remedy, and his team has completed their evaluation of the manufactured samples of Emesyl(TM), the company's over-the-counter homeopathic product for nausea relief.
Itonis, Inc. Signs LOI With MyECheck, Inc. for Licensing of App for Medical Marijuana Point of Purchase
Marketwire - Mon Mar 17, 2:29PM CDT
Itonis, Inc. (PINKSHEETS: ITNS) is pleased to announce that it has entered into a Letter of Intent with MyECheck, Inc. to acquire a software license for MyECheck's patented mobile payment app that will facilitate point of purchase transactions for medical marijuana, gambling, and general retail sales.
Itonis Pharmaceuticals Received Emesyl Samples for Evaluation
Marketwire - Fri Feb 28, 12:50PM CST
Itonis, Inc. (PINKSHEETS: ITNS) is pleased to announce that it has received and is currently evaluating samples of its Emesyl(TM) product from its manufacturer. Oasis Health Products, Inc. delivered two versions of the Emesyl(TM) anti-nausea formula which are currently being evaluating for tolerance.
Itonis Pharmaceuticals and Charles Hensley, Ph.D. to Begin Distributing Emesyl(TM) Anti-Nausea Homeopathic Product in Mexico
Marketwire - Thu Sep 12, 7:30AM CDT
Itonis, Inc.'s pharmaceutical division (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) Cold Remedy, are pleased to announce that Hensley Brothers Distribution, LLC ("HBD"
will distribute Emesyl((TM)), the Company's over-the-counter homeopathic product for nausea relief, to Mexico through one of HBD's distribution partners. Itonis Pharmaceuticals, Led by Dr. Charles Hensley, the Inventor of Zicam(R) Cold Remedy, Received FDA Labeler Status
Marketwire - Wed Jul 31, 8:02AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce that the Company has received its labeler's code from the federal Food and Drug Administration (FDA).
Charles Hensley, Ph.D., Inventor of Zicam(R) Cold Remedy, and Itonis Pharmaceuticals to Distribute Homeopathic Products in Retail Chains
Marketwire - Fri Jul 19, 8:45AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce that the Company's line of homeopathic products will be distributed nationally and internationally by Hensley Brothers Distribution, LLC.
Charles Hensley, Ph.D., Inventor of Zicam(R) Cold Remedy, and Itonis Pharmaceuticals to Obtain FDA Labeler Status
Marketwire - Tue Jun 25, 1:30PM CDT
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce the Company has commenced the application process to file with the U.S. Food and Drug Administration as a labeler.
Charles Hensley, Ph.D., Inventor of Zicam(r) Cold Remedy, And Itonis Pharmaceuticals Prepared to File for the National Drug Code Number for the Emesyl(tm) Anti-Nausea Products to Launch Sales in Fall 2013
GlobeNewswire - Fri May 31, 8:30AM CDT
Itonis, Inc. (OTC: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) Cold Remedy, and founding member of Itonis Pharmaceuticals, are pleased to announce the Company is prepared to file for the National Drug Code (NDC) number for their over-the-counter Emesyl(TM) homeopathic product.
Charles Hensley, Ph.D., Inventor of Zicam(r) Cold Remedy And Itonis Pharmaceuticals to Finalized Product Packaging For The Emesyl Anti-Nausea Products
GlobeNewswire - Thu May 30, 11:53AM CDT
Itonis, Inc. (OTC: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) Cold Remedy, and founding member of Itonis Pharmaceuticals, are pleased to announce the finalization of the packaging graphics for their over-the-counter homeopathic product EmesylTM which can be viewed at the Company's website at www.itonisholdings.com.
Charles Hensley, Ph.D., Inventor of Zicam(r) Cold Remedy And Itonis Pharmaceuticals Finalized Product Packaging For The Emesyl Anti-Nausea Products
GlobeNewswire - Thu May 30, 10:00AM CDT
Itonis, Inc. (OTC: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) Cold Remedy, and founding member of Itonis Pharmaceuticals, are pleased to announce the finalization of the packaging graphics for their over-the-counter homeopathic product EmesylTM which can be viewed at the Company's website at www.itonisholdings.com.
